Plasma testosterone in patients receiving diethylstilbestrol

Phillip H. Beck; Jack W. McAninch; James L. Goebel; Ray E. Stutzman

doi:10.1016/0090-4295(78)90096-1

Plasma testosterone in patients receiving diethylstilbestrol

Phillip H. Beck, Jack W. McAninch, James L. Goebel, Ray E. Stutzman

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

With accurate, inexpensive plasma testosterone assays now available it is possible to monitor the efficacy of hormonal manipulation in the patient with adenocarcinoma of the prostate. We monitored plasma testosterone in our patients receiving diethylstilbestrol (DES) 1 mg. per day. We found no statistical difference in mean plasma testosterone between patients with adenocarcinoma of the prostate and castrated patients with prostatic carcinoma, all receiving DES, 1 mg. per day. We recommend that plasma testosterone be closely monitored in patients receiving hormonal therapy for adenocarcinoma of the prostate.

Original language	English (US)
Pages (from-to)	157-160
Number of pages	4
Journal	Urology
Volume	11
Issue number	2
DOIs	https://doi.org/10.1016/0090-4295(78)90096-1
State	Published - Feb 1978
Externally published	Yes

ASJC Scopus subject areas

Urology

Access to Document

10.1016/0090-4295(78)90096-1

Cite this

@article{90f86c39fe3f4521870e860ece484101,

title = "Plasma testosterone in patients receiving diethylstilbestrol",

abstract = "With accurate, inexpensive plasma testosterone assays now available it is possible to monitor the efficacy of hormonal manipulation in the patient with adenocarcinoma of the prostate. We monitored plasma testosterone in our patients receiving diethylstilbestrol (DES) 1 mg. per day. We found no statistical difference in mean plasma testosterone between patients with adenocarcinoma of the prostate and castrated patients with prostatic carcinoma, all receiving DES, 1 mg. per day. We recommend that plasma testosterone be closely monitored in patients receiving hormonal therapy for adenocarcinoma of the prostate.",

author = "Beck, {Phillip H.} and McAninch, {Jack W.} and Goebel, {James L.} and Stutzman, {Ray E.}",

year = "1978",

month = feb,

doi = "10.1016/0090-4295(78)90096-1",

language = "English (US)",

volume = "11",

pages = "157--160",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Plasma testosterone in patients receiving diethylstilbestrol

AU - Beck, Phillip H.

AU - McAninch, Jack W.

AU - Goebel, James L.

AU - Stutzman, Ray E.

PY - 1978/2

Y1 - 1978/2

N2 - With accurate, inexpensive plasma testosterone assays now available it is possible to monitor the efficacy of hormonal manipulation in the patient with adenocarcinoma of the prostate. We monitored plasma testosterone in our patients receiving diethylstilbestrol (DES) 1 mg. per day. We found no statistical difference in mean plasma testosterone between patients with adenocarcinoma of the prostate and castrated patients with prostatic carcinoma, all receiving DES, 1 mg. per day. We recommend that plasma testosterone be closely monitored in patients receiving hormonal therapy for adenocarcinoma of the prostate.

AB - With accurate, inexpensive plasma testosterone assays now available it is possible to monitor the efficacy of hormonal manipulation in the patient with adenocarcinoma of the prostate. We monitored plasma testosterone in our patients receiving diethylstilbestrol (DES) 1 mg. per day. We found no statistical difference in mean plasma testosterone between patients with adenocarcinoma of the prostate and castrated patients with prostatic carcinoma, all receiving DES, 1 mg. per day. We recommend that plasma testosterone be closely monitored in patients receiving hormonal therapy for adenocarcinoma of the prostate.

UR - http://www.scopus.com/inward/record.url?scp=0017837839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017837839&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(78)90096-1

DO - 10.1016/0090-4295(78)90096-1

M3 - Article

C2 - 628992

AN - SCOPUS:0017837839

SN - 0090-4295

VL - 11

SP - 157

EP - 160

JO - Urology

JF - Urology

IS - 2

ER -

Plasma testosterone in patients receiving diethylstilbestrol

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this